Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Discovery of FabH/FabF Inhibitors from Natural Products

Open access
Young, Katherine, Jayasuriya, Hiranthi, Ondeyka, John G., Herath, Kithsiri, Zhang, Chaowei, Kodali, Srinivas, Galgoci, Andrew, Painter, Ronald, Brown-Driver, Vickie, Yamamoto, Robert, Silver, Lynn L., Zheng, Yingcong, Ventura, Judith I., Sigmund, Janet, Ha, Sookhee, Basilio, Angela, Vicente, Francisca, Tormo, José Rubén, Pelaez, Fernando, Youngman, Phil, Cully, Doris, Barrett, John F., Schmatz, Dennis, Singh, Sheo B., Wang, Jun·2006·Antimicrobial Agents and Chemotherapy

Abstract

Condensing enzymes are essential in type II fatty acid synthesis and are promising targets for antibacterial drug discovery. Recently, a new approach using a xylose-inducible plasmid to express antisense RNA in Staphylococcus aureus has been described; however, the actual mechanism was not delineated. In this paper, the mechanism of decreased target protein production by expression of antisense RNA was investigated using Northern blotting. This revealed that the antisense RNA acts posttranscriptionally by targeting mRNA, leading to 5′ mRNA degradation. Using this technology, a two-plate assay was developed in order to identify FabF/FabH target-specific cell-permeable inhibitors by screening of natural product extracts. Over 250,000 natural product fermentation broths were screened and then confirmed in biochemical assays, yielding a hit rate of 0.1%. All known natural product FabH and FabF inhibitors, including cerulenin, thiolactomycin, thiotetromycin, and Tü3010, were discovered using this whole-cell mechanism-based screening approach. Phomallenic acids, which are new inhibitors of FabF, were also discovered. These new inhibitors exhibited target selectivity in the gel elongation assay and in the whole-cell-based two-plate assay. Phomallenic acid C showed good antibacterial activity, about 20-fold better than that of thiolactomycin and cerulenin, against S. aureus . It exhibited a spectrum of antibacterial activity against clinically important pathogens including methicillin-resistant Staphylococcus aureus , Bacillus subtilis , and Haemophilus influenzae .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.50.2.519-526.2006

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 202

Metadata

Authors
Young, K., Jayasuriya, H., Ondeyka, J. G., Herath, K., Zhang, C., Kodali, S., Galgoci, A., Painter, R., Brown-Driver, V., Yamamoto, R., Silver, L. L., Zheng, Y., Ventura, J. I., Sigmund, J., Ha, S., Basilio, A., Vicente, F., Tormo, J. R., Pelaez, F., Youngman, P., Cully, D., Barrett, J. F., Schmatz, D., Singh, S. B., & Wang, J.
Venue
Antimicrobial Agents and Chemotherapy
Published
2006-02
Volume
50
Issue
2
Pages
519-526
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2164667097
Cited by
202
References
2
FWCI
12.26
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of FabH/FabF Inhibitors from Natural Products. https://app.cochat.ai/papers/10.1128/aac.50.2.519-526.2006
The paper
Young, K., Jayasuriya, H., Ondeyka, J. G., Herath, K., Zhang, C., Kodali, S., Galgoci, A., Painter, R., Brown-Driver, V., Yamamoto, R., Silver, L. L., Zheng, Y., Ventura, J. I., Sigmund, J., Ha, S., Basilio, A., Vicente, F., Tormo, J. R., Pelaez, F., . . . Wang, J. (2006). Discovery of FabH/FabF Inhibitors from Natural Products. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.50.2.519-526.2006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.